Cargando…
CTBP1-AS upregulation is associated with polycystic ovary syndrome and can be effectively downregulated by cryptotanshinone
Polycystic ovary syndrome (PCOS) is one of the most common endocrinopathies and primarily presents with hyperandrogenism. Although environmental factors and genetic factors are thought to be the major reason, there still exists a lot of questions need to be answered. High expression of C-terminal-bi...
Autores principales: | Wen, Mingxiao, Dou, Xiaoqing, Zhang, Shuzhen, Wang, Bin, Xu, Jiangyan, Zhang, Wenchao, Wang, Feifei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185693/ https://www.ncbi.nlm.nih.gov/pubmed/35656892 http://dx.doi.org/10.3892/mmr.2022.12761 |
Ejemplares similares
-
Long Noncoding RNA FOXD2-AS1 Promotes the Malignancy of Cervical Cancer by Sponging MicroRNA-760 and Upregulating Hepatoma-Derived Growth Factor
por: Dou, Xiaoqing, et al.
Publicado: (2020) -
Cryptotanshinone alleviates polycystic ovary syndrome in rats by regulating the HMGB1/TLR4/NF-κB signaling pathway
por: Yang, Yijiao, et al.
Publicado: (2020) -
HBV Upregulates CtBP2 Expression via the X Gene
por: Liu, Xinghui, et al.
Publicado: (2018) -
CTBP1 and CTBP2 mutations underpinning neurological disorders: a systematic review
por: Acosta-Baena, Natalia, et al.
Publicado: (2022) -
Downregulated Expression of Peroxiredoxin 4 in Granulosa Cells from Polycystic Ovary Syndrome
por: Meng, Yan, et al.
Publicado: (2013)